- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech High Growth Potential Companies
Swiss Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Apr 22, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NWRN | CHF7.18 | -0.6% | 59.6% | CHF133.8m | CHF13.01 | PS15.2x | E53.3% | n/a | ||
BSLN | CHF40.90 | -0.5% | -6.6% | CHF490.9m | CHF70.58 | PE47x | E32.4% | 0% | ||
COPN | CHF73.40 | 4.1% | 34.2% | CHF1.2b | CHF93.67 | PE1056.9x | E30.4% | 2.6% | ||
SKAN | CHF77.90 | -5.7% | -10.7% | CHF1.8b | CHF91.33 | PE66.6x | E34.8% | 0.4% | ||
SDZ | CHF31.02 | 11.1% | n/a | CHF13.3b | CHF35.13 | PE189.8x | E29.7% | 1.4% | ||
TECN | CHF322.60 | -4.3% | -19.2% | CHF4.1b | CHF395.57 | PE31.3x | E9.2% | 0.9% | ||
NOVN | CHF87.36 | 2.8% | -6.2% | CHF191.3b | CHF96.36 | PE24.5x | E10.2% | 3.8% | ||
BANB | CHF78.40 | -1.9% | -17.9% | CHF5.9b | CHF70.80 | PE52.5x | E15.4% | 1.0% | ||
ROG | CHF225.80 | 1.9% | -19.9% | CHF182.0b | CHF281.06 | PE15.7x | E8.2% | 4.3% | ||
ADXN | CHF0.15 | -12.0% | 30.5% | CHF19.8m | n/a | PS12x | E94.0% | n/a | ||
LONN | CHF506.80 | -3.7% | -9.0% | CHF36.5b | CHF566.00 | PE55.9x | E19.9% | 0.8% | ||
SFZN | CHF884.00 | -0.2% | 28.5% | CHF3.8b | CHF1,015.90 | PE33.6x | E14.7% | 0.4% | ||
PPGN | CHF28.25 | -2.1% | 39.4% | CHF931.4m | CHF21.55 | PS3x | E0.07% | 0% |
Page 1 of 1